Today's Date: March 26, 2023
Philadelphia Works Names First Female Chief Operating Officer   •   National University Receives 2023 Military Friendly® Gold Designation   •   SOTERA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Sote   •   SOTERA HEALTH 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Los   •   NATIONAL VISION DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Aga   •   GINKGO BIOWORKS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Office   •   SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Stanley Black & Decker, Inc. with Losses of $100,000 t   •   ImmunoGen Presents Final Overall Survival and Additional Efficacy Data from the SORAYA Trial at SGO Annual Meeting   •   SAMARITAN'S PURSE RUSHING HELP TO FAMILIES IMPACTED BY DEADLY TORNADOES IN MISSISSIPPI   •   Build community with shared future, create better world   •   Korelya Capital Invests in Weo, Bringing Total Funds Raised to $15M, and Leads Launch of its Series A Financing Round   •   Atlanta Housing, Residents Celebrate 102nd Birthday of Clara "Mama" Bridges   •   ARGO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Argo B   •   Otr Elkalam: All the Way from Hollywood to Riyadh An American Contestant Travels to Participate in the Largest Religious Competi   •   Statement from the Chief Public Health Officer of Canada on World TB Day   •   SBNY LOSS ALERT: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages Signature Bank Investors to Secure Counsel Before Important D   •   Early Education Leadership Conference in Hershey Brings Together Hundreds of Child Advocates   •   Jennifer S. Wilkov Finalizes Lineup for the 2023 April Speak Up Women Conference   •   HYZON MOTORS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers   •   DISH ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against DISH Network Corporatio
Bookmark and Share

MIP Discovery Secures Significant Funding to Support Development of Global Rapid Response Diagnostics

BEDFORDSHIRE, England , February 01 /Businesswire/ - MIP Discovery, a leader in rationally designed detection reagents based on its proprietary nanoMIPtechnology, has today announced it has secured a significant grant of funds from the Bill & Melinda Gates Foundation. The innovative project will focus on the use of MIP Discovery’s animal/cell free detection reagents as an improvement over antibodies, to quickly enable low-cost, high volume diagnostic tests, for low and middle-income countries during endemic or pandemic outbreaks.

Deployment of effective diagnostic testing is key to managing disease outbreaks at the regional or global level. The challenge is being able to design a diagnostic quickly, that can also be scaled up in a short period of time for widespread use. Traditional approaches using antibodies are challenged to meet the timeline, volume or performance requirements of a pandemic. MIP Discovery and other technology partners selected by the foundation are collaborating to advance a novel roadmap for diagnostics at mass scale in response to endemic or pandemic outbreaks.

MIP Discovery’s proprietary imprinted polymer technology is able to meet the requirements both for speed and scale of novel recognition reagents. The Company is optimising processes that will be significantly faster than novel antibody production, which is fundamentally rate limited by biological processes such as cell culture. MIP Discovery aims to reduce current timelines to allow design and scale up of novel detection reagents in under 4 weeks. nanoMIP detection reagents can then be deployed using massively high throughput diagnostic platforms or lateral flow devices. A ‘scale out’ approach will allow MIP Discovery to tackle multiple diagnostic markers at once, whilst still achieving the volumes required for mass scale diagnostics.

Stephane Argivier, CEO, MIP Discovery, said: “COVID-19 taught the world the importance of pandemic preparedness, particularly the importance of effective deployment of diagnostic testing. We are proud to be aligned with the foundation and other partners such as Flexotronix, a Sapphiros company, in developing new approaches to delivering diagnostic disease testing on a global basis. Our proprietary nanoMIP technology will redefine how the world will respond to endemic and pandemic crises, whether natural or otherwise.”

“Pandemics are very much global events which require rapid global responses. This programme, driven by the foundation funding is a key step in the development of high volume, cost-effective IVD tools that provide a rapidly scalable solution to sudden demand for any infectious disease crisis, whether these are known conditions such as Ebola or emerging viruses similar to recent strains of COVID-19.” said Mike Evans, Chairman, MIP Discovery.


STORY TAGS: Research, Philanthropy, Pharmaceutical, Technology, Medical Devices, Infectious Diseases, Foundation, Clinical Trials, Science, Nanotechnology, Biotechnology, Health, Other Science, Funding, Product/Service, United Kingdom, Europe,


White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News